We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Third Time Not the Charm for Iluvien Eye Treatment
Third Time Not the Charm for Iluvien Eye Treatment
October 25, 2013
The FDA has issued a third complete response letter (CRL) to Alimera, asking for additional clinical trial data to address some identified statistical deficiencies with the drugmaker’s Iluvien macular edema treatment.